Mixing COVID vaccines generates a comparable immune response
The three major COVID-19 vaccines, Moderna, Pfizer-BioNTech, and AstraZeneca, are based on two technologies: messenger
Immune Response
Robust T cell and humoral immune response to SARS-CoV-2 in patients with immunodeficiency
A study of immune-deficient adults and children has shown that patients who fail to respond
How likely is SARS-CoV-2 reinfection?
The coronavirus disease 2019 (COVID-19) pandemic has already caused over 117.6 million confirmed cases the
New molecule passes toxicology testing to treat multiple sclerosis
Brazilian researchers who study a native venomous fish have confirmed a route to drug development
SARS-CoV-2 ORF7a mutation limits host immune suppression, finds study
Besides the highly publicized spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a
In Vivo Probes for Detecting Inflammation Markers in Humans and Animals
Thought LeadersProf. Parastoo HashemiAssistant Professor of ChemistryDepartment of Chemistry and BiochemistryUniversity of South Carolina In